Journal article
Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor
The Journal of experimental medicine, Vol.215(2), pp.661-679
02/05/2018
DOI: 10.1084/jem.20170396
PMCID: PMC5789406
PMID: 29282252
Abstract
Iron-restricted human anemias are associated with the acquisition of marrow resistance to the hematopoietic cytokine erythropoietin (Epo). Regulation of Epo responsiveness by iron availability serves as the basis for intravenous iron therapy in anemias of chronic disease. Epo engagement of its receptor normally promotes survival, proliferation, and differentiation of erythroid progenitors. However, Epo resistance caused by iron restriction selectively impairs proliferation and differentiation while preserving viability. Our results reveal that iron restriction limits surface display of Epo receptor in primary progenitors and that mice with enforced surface retention of the receptor fail to develop anemia with iron deprivation. A mechanistic pathway is identified in which erythroid iron restriction down-regulates a receptor control element, Scribble, through the mediation of the iron-sensing transferrin receptor 2. Scribble deficiency reduces surface expression of Epo receptor but selectively retains survival signaling via Akt. This mechanism integrates nutrient sensing with receptor function to permit modulation of progenitor expansion without compromising survival.
Details
- Title: Subtitle
- Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor
- Creators
- Shadi Khalil - University of VirginiaLorrie Delehanty - University of VirginiaStephen Grado - University of VirginiaMaja Holy - University of VirginiaZollie White III - University of VirginiaKatie Freeman - University of VirginiaRyo Kurita - RIKEN BioResource Research CenterYukio Nakamura - RIKEN BioResource Research CenterGrant Bullock - University of Pittsburgh Medical CenterAdam Goldfarb - University of Virginia
- Resource Type
- Journal article
- Publication Details
- The Journal of experimental medicine, Vol.215(2), pp.661-679
- DOI
- 10.1084/jem.20170396
- PMID
- 29282252
- PMCID
- PMC5789406
- NLM abbreviation
- J Exp Med
- ISSN
- 0022-1007
- eISSN
- 1540-9538
- Grant note
- R01 DK101550 / NIDDK NIH HHS P30 CA044579 / NCI NIH HHS R01 DK079924 / NIDDK NIH HHS T32 CA009109 / NCI NIH HHS K08 HL093355 / NHLBI NIH HHS T32 GM007267 / NIGMS NIH HHS
- Language
- English
- Date published
- 02/05/2018
- Academic Unit
- Pathology
- Record Identifier
- 9984697642702771
Metrics
8 Record Views